Related Experiment Videos
10 years of patch testing with the (meth)acrylate series
L Kanerva1, R Jolanki, T Estlander
1Section of Dermatology, Finnish Institute of Occupational Health, Helsinki, Finland.
Contact Dermatitis
|February 10, 1998
Summary
Patch testing revealed that 17.5% of patients had allergic reactions to (meth)acrylates. 2-hydroxyethyl acrylate (2-HEA) and 2-hydroxypropyl methacrylate (2-HPMA) were common allergens, but definitive sensitization rankings require more exposure data.
Area of Science:
- Dermatology
- Allergology
- Toxicology
Background:
- (Meth)acrylates are widely used in various industries.
- Occupational and consumer exposure to (meth)acrylates can lead to allergic contact dermatitis.
- Understanding the sensitization potential of individual (meth)acrylates is crucial for risk assessment.
Purpose of the Study:
- To compile and analyze 10 years of patch testing data for 30 (meth)acrylates.
- To identify the most frequent (meth)acrylates causing allergic reactions in patients.
- To assess the limitations in determining the sensitization capacity of (meth)acrylates based on current data.
Main Methods:
- Retrospective analysis of patch test results from 275 patients over a 10-year period.
- Testing involved 30 different (meth)acrylate substances.
- Data collected on patient demographics and patch test reactions.
Main Results:
- 48 out of 275 patients (17.5%) showed allergic reactions to at least one (meth)acrylate.
- The most common allergens were 2-hydroxyethyl acrylate (2-HEA; 12.1%), 2-hydroxypropyl methacrylate (2-HPMA; 12.0%), and 2-hydroxyethyl methacrylate (2-HEMA; 11.4%).
- Several (meth)acrylates, including 2-ethylhexyl acrylate (2-EHA) and ethyl cyanoacrylate (ECA), did not elicit any allergic reactions in this cohort.
Conclusions:
- While certain (meth)acrylates are more frequently associated with allergic reactions, this data cannot establish a definitive sensitization ranking.
- Accurate assessment of (meth)acrylate sensitization requires detailed patient exposure history and information on the purity of tested substances.
- The presence of undeclared (meth)acrylates in commercial products complicates the evaluation of sensitization risks.